Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations
Santanu Sasidharan, Chandrabose Selvaraj, Sanjeev Kumar Singh, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 15, pp. 5706-5721
Closed Access | Times Cited: 24

Showing 24 citing articles:

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
New generation of cell‐penetrating peptides: Functionality and potential clinical application
Siegmund Reißmann, Margarita P. Filatova
Journal of Peptide Science (2021) Vol. 27, Iss. 5
Open Access | Times Cited: 55
Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein
Rodrigo A. Moreira, Horacio V. Guzman, Subramanian Boopathi, et al.
Materials (2020) Vol. 13, Iss. 23, pp. 5362-5362
Open Access | Times Cited: 54
Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations
Anastasiia I. Petushkova, Andrey A. Zamyatnin
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 277-277
Open Access | Times Cited: 47
SARS-CoV-2 ORF8 dimerization and binding mode analysis with class I MHC: computational approaches to identify COVID-19 inhibitors
Chandrabose Selvaraj, Dhurvas Chandrasekaran Dinesh, Emilia Pedone, et al.
Briefings in Functional Genomics (2023) Vol. 22, Iss. 2, pp. 227-240
Closed Access | Times Cited: 9
Characterization of structural and energetic differences between conformations of the SARS-CoV-2 spike protein
Rodrigo A. Moreira, Horacio V. Guzman, Subramanian Boopathi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 25
Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates
Mateus Sá Magalhães Serafim, Jadson Castro Gertrudes, Débora Maria Abrantes Costa, et al.
Bioscience Reports (2021) Vol. 41, Iss. 3
Open Access | Times Cited: 19
Rational Discovery of Antiviral Whey Protein-Derived Small Peptides Targeting the SARS-CoV-2 Main Protease
Nicola Gambacorta, Leonardo Caputo, Laura Quintieri, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1067-1067
Open Access | Times Cited: 13
Machine learning combines atomistic simulations to predict SARS-CoV-2 Mpro inhibitors from natural compounds
Trung Hai Nguyen, Quynh Mai Thai, Phạm Minh Quân, et al.
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 553-561
Open Access | Times Cited: 6
Drugs repurposing against SARS-CoV2 and the new variant B.1.1.7 (alpha strain) targeting the spike protein: molecular docking and simulation studies
Monu Pande, Debanjan Kundu, Ragini Srivastava
Heliyon (2021) Vol. 7, Iss. 8, pp. e07803-e07803
Open Access | Times Cited: 15
SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
П. В. Ершов, Е.O. Yablokov, Yuri V. Mezentsev, et al.
BIOPHYSICS (2022) Vol. 67, Iss. 6, pp. 902-912
Open Access | Times Cited: 8
Biomolecular interactions with nanoparticles: applications for coronavirus disease 2019
Mohammed A. H. Farouq, Mohammed M. Al Qaraghuli, Karina Kubiak-Ossowska, et al.
Current Opinion in Colloid & Interface Science (2021) Vol. 54, pp. 101461-101461
Open Access | Times Cited: 11
Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19
Sundaresan Bhavaniramya, Ramar Vanajothi, Selvaraju Vishnupriya, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 2, pp. 393-417
Closed Access | Times Cited: 6
Discovery of compounds inhibiting SARS-COV-2 multi-targets
Santanu Sasidharan, Neellohit Sarkar, Prakash Saudagar
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 6, pp. 2602-2617
Closed Access | Times Cited: 4
Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics
Chandrabose Selvaraj, Dhurvas Chandrasekaran Dinesh, Petra Krafčíková, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 2, pp. 418-433
Closed Access | Times Cited: 5
Therapeutic p28 peptide targets essential H1N1 influenza virus proteins: insights from docking and molecular dynamics simulations
Santanu Sasidharan, Vijayakumar Gosu, Donghyun Shin, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1929-1943
Open Access | Times Cited: 4
Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19
J. Kumaravel, Harvinder Singh, Sukhmeet Kaur, et al.
Indian Journal of Pharmacology (2023) Vol. 55, Iss. 1, pp. 53-58
Open Access | Times Cited: 1
Molecular dynamics-driven exploration of peptides targeting SARS-CoV-2, with special attention on ACE2, S protein, Mpro, and PLpro: A review
MOHAMAD ZULKEFLEE SABRI, Joanna Bojarska, Fai‐Chu Wong, et al.
Biocell (2023) Vol. 47, Iss. 8, pp. 1727-1742
Open Access | Times Cited: 1
Mechanistic Insights into Targeting SARS-CoV-2 Papain-Like Protease in the Evolution and Management of COVID-19: A Comprehensive Review
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
(2023)
Open Access | Times Cited: 1
Pathogen-derived peptides in drug targeting and its therapeutic approach
Seok‐Jun Mun, Euni Cho, Jae‐Sung Kim, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 716-733
Closed Access | Times Cited: 2
In silico prediction of deleterious single nucleotide polymorphism in human AKR1C3 gene and identification of potent inhibitors using molecular docking approach
Saleh Abdullah Aloyuni
Journal of King Saud University - Science (2021) Vol. 33, Iss. 6, pp. 101514-101514
Open Access | Times Cited: 2
Prediction of SARS-CoV-2 3C-like protease (3CLpro) crystal structure to provide COVID-19 inhibitor design through computational studies
Taufik Muhammad Fakih, Dwi Syah Fitra Ramadhan
Biogenesis Jurnal Ilmiah Biologi (2021) Vol. 9, Iss. 2, pp. 213-219
Open Access | Times Cited: 1
Herbal medicine (Curcuma longa) inspired volatile compounds as potential inhalants against SARS-CoV-2: An in-silico strategy and modeling study
J. Jayashankar, M. S. Punith, S. Nanjundaswamy, et al.
Research Square (Research Square) (2023)
Open Access
From exploring cancer and virus targets to discovering active peptides through mRNA display
José Brango‐Vanegas, Michel Lopes Leite, Kamila Botelho Sampaio de Oliveira, et al.
Pharmacology & Therapeutics (2023) Vol. 252, pp. 108559-108559
Closed Access
Page 1

Scroll to top